OBJECTIVE: Autism spectrum disorder (ASD) is a heritable but highly heterogeneous neuropsychiatric syndrome, which poses challenges for research relying solely on behavioral symptoms or diagnosis. Examining biomarkers may give us ways to identify individuals who demonstrate specific developmental trajectories and etiological factors related to ASD. Plasma oxytocin (OT) and whole-blood serotonin (5-HT) levels are consistently altered in some individuals with ASD. Reciprocal relationships have been described between brain oxytocin and serotonin systems during development. We therefore investigated the relationship between these peripheral biomarkers as well as their relationships with age. METHOD: In our first study, we analyzed correlations between these two biomarkers in 31 children and adolescents who were diagnosed with autism and were not on medications. In our second study, we explored whether whole-blood 5-HT levels are altered in mice lacking the oxytocin receptor gene Oxtr. RESULTS: In humans, OT and 5-HT were negatively correlated with each other (p < .05) and this relationship was most prominent in children less than 11 years old. Paralleling human findings, mice lacking Oxtr showed increased whole-blood 5-HT levels (p = .05), with this effect driven exclusively by mice less than 4 months old (p < .01). CONCLUSIONS: Identifying relationships between identified ASD biomarkers may be a useful approach to connect otherwise disparate findings that span multiple systems in this heterogeneous disorder. Using neurochemical biomarkers to perform parallel studies in animal and human populations within a developmental context is a plausible approach to probe the root causes of ASD and to identify potential interventions.
OBJECTIVE:Autism spectrum disorder (ASD) is a heritable but highly heterogeneous neuropsychiatric syndrome, which poses challenges for research relying solely on behavioral symptoms or diagnosis. Examining biomarkers may give us ways to identify individuals who demonstrate specific developmental trajectories and etiological factors related to ASD. Plasma oxytocin (OT) and whole-blood serotonin (5-HT) levels are consistently altered in some individuals with ASD. Reciprocal relationships have been described between brain oxytocin and serotonin systems during development. We therefore investigated the relationship between these peripheral biomarkers as well as their relationships with age. METHOD: In our first study, we analyzed correlations between these two biomarkers in 31 children and adolescents who were diagnosed with autism and were not on medications. In our second study, we explored whether whole-blood 5-HT levels are altered in mice lacking the oxytocin receptor gene Oxtr. RESULTS: In humans, OT and 5-HT were negatively correlated with each other (p < .05) and this relationship was most prominent in children less than 11 years old. Paralleling human findings, mice lacking Oxtr showed increased whole-blood 5-HT levels (p = .05), with this effect driven exclusively by mice less than 4 months old (p < .01). CONCLUSIONS: Identifying relationships between identified ASD biomarkers may be a useful approach to connect otherwise disparate findings that span multiple systems in this heterogeneous disorder. Using neurochemical biomarkers to perform parallel studies in animal and human populations within a developmental context is a plausible approach to probe the root causes of ASD and to identify potential interventions.
Authors: Stelios Georgiades; Peter Szatmari; Lonnie Zwaigenbaum; Eric Duku; Susan Bryson; Wendy Roberts; Jeremy Goldberg; William Mahoney Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-02 Impact factor: 8.829
Authors: Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie Journal: Biol Psychiatry Date: 2009-11-07 Impact factor: 13.382
Authors: C Sue Carter; Angela J Grippo; Hossein Pournajafi-Nazarloo; Michael G Ruscio; Stephen W Porges Journal: Prog Brain Res Date: 2008 Impact factor: 2.453
Authors: Matthew Mazalouskas; Tammy Jessen; Seth Varney; James S Sutcliffe; Jeremy Veenstra-VanderWeele; Edwin H Cook; Ana M D Carneiro Journal: Neuropsychopharmacology Date: 2015-02-16 Impact factor: 7.853
Authors: Jill D Jacobson; Kathryn A Ellerbeck; Kelsie A Kelly; Kandace K Fleming; T Rene Jamison; Charles W Coffey; Catherine M Smith; R Matthew Reese; Scott A Sands Journal: Psychoneuroendocrinology Date: 2013-11-26 Impact factor: 4.905
Authors: J H Pagani; S K Williams Avram; Z Cui; J Song; É Mezey; J M Senerth; M H Baumann; W S Young Journal: Genes Brain Behav Date: 2015-03-05 Impact factor: 3.449
Authors: Suena H Massey; Stephanie A Schuette; Hossein Pournajafi-Nazarloo; Katherine L Wisner; C Sue Carter Journal: Arch Womens Ment Health Date: 2016-03-08 Impact factor: 3.633
Authors: L Kobylinska; A M Panaitescu; G Gabreanu; C G Anghel; I Mihailescu; F Rad; C Nedelcu; I Mocanu; C Constantin; S V Badescu; I Dobrescu; M Neagu; O I Geicu; L Zagrean; A M Zagrean Journal: Acta Endocrinol (Buchar) Date: 2019 Jan-Mar Impact factor: 0.877